This site is intended for healthcare professionals
News

Phase III TIMES 2 and 3 trials of imeglimin meet primary endpoints in type 2 diabetes.- Poxel

Read time: 2 mins
Last updated:28th Sep 2020
Published:26th Sep 2020
Condition: Diabetes Type 2
Type: drug
Register free for full access to medthority.com